Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Tax Provisions (2022 - 2025)

Historic Tax Provisions for Arcturus Therapeutics Holdings (ARCT) over the last 4 years, with Q2 2025 value amounting to $4000.0.

  • Arcturus Therapeutics Holdings' Tax Provisions rose 10200.0% to $4000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$217000.0, marking a year-over-year decrease of 11625.47%. This contributed to the annual value of -$4000.0 for FY2024, which is 10021.8% down from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Tax Provisions stood at $4000.0 for Q2 2025, which was up 10200.0% from -$4000.0 recorded in Q4 2024.
  • In the past 5 years, Arcturus Therapeutics Holdings' Tax Provisions registered a high of $900000.0 during Q3 2023, and its lowest value of -$217000.0 during Q3 2024.
  • For the 4-year period, Arcturus Therapeutics Holdings' Tax Provisions averaged around $192100.0, with its median value being $101500.0 (2022).
  • Over the last 5 years, Arcturus Therapeutics Holdings' Tax Provisions had its largest YoY gain of 28834.95% in 2024, and its largest YoY loss of 13333.33% in 2024.
  • Quarter analysis of 4 years shows Arcturus Therapeutics Holdings' Tax Provisions stood at $100000.0 in 2022, then soared by 135.0% to $235000.0 in 2023, then crashed by 101.7% to -$4000.0 in 2024, then surged by 200.0% to $4000.0 in 2025.
  • Its Tax Provisions stands at $4000.0 for Q2 2025, versus -$4000.0 for Q4 2024 and -$217000.0 for Q3 2024.